Align Technology Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Align Technology şirketinin toplam hissedar öz sermayesi $3.9B ve toplam borcu $0.0 olup, bu da borç-öz sermaye oranını 0% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $6.4B ve $2.4B dir. Align Technology 'in FAVÖK'ü $679.5M faiz karşılama oranı -40.8 dur. Şirketin $1.0B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

Borç/özkaynak oranı

US$0

Borç

Faiz karşılama oranı	-40.8x
Nakit	US$1.04b
Eşitlik	US$3.94b
Toplam yükümlülükler	US$2.42b
Toplam varlıklar	US$6.37b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 0HCK 'nin kısa vadeli varlıkları ( $2.6B ) kısa vadeli yükümlülüklerini ( $2.1B ) aşıyor.

Uzun Vadeli Yükümlülükler: 0HCK şirketinin kısa vadeli varlıkları ( $2.6B ) uzun vadeli yükümlülüklerini ( $358.0M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 0HCK borçsuzdur.

Borcun Azaltılması: 0HCK son 5 yıldır borcu bulunmamaktadır.

Borç Kapsamı: 0HCK un borcu yoktur, dolayısıyla işletme nakit akışı tarafından karşılanmasına gerek yoktur.

Faiz Kapsamı: 0HCK şirketinin borcu bulunmadığından faiz ödemelerinin karşılanması söz konusu değildir.

Align Technology Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Align Technology, Inc Announces the Release of the Next Innovation of Invisalign Smile Architect Software

Third quarter 2024 earnings released: EPS: US$1.55 (vs US$1.59 in 3Q 2023)

Align Technology, Inc. Provides Earnings Guidance for the Fourth Quarter of 2024

Invisalign Palatal Expander System by Align Technology, Inc. Now Available in Singapore for Skeletal and Dental Expansion in Growing Patients

Align Technology, Inc. Announces Court Grants Preliminary Approval of Settlement to Resolve All Outstanding Shareholder Derivative Litigation

Align Technology Announces New Regional Leadership Roles

Independent Chairman recently bought US$1.5m worth of stock

Align Technology, Inc. Provides Earnings Guidance for the Third Quarter and Full Year of Fiscal 2024

Second quarter 2024 earnings released: EPS: US$1.28 (vs US$1.46 in 2Q 2023)

Align Technology, Inc. Introduces iTero Design Suite, Enabling Intuitive Design Capabilities for In-Practice 3D Printing to Boost Practice Efficiency

Now 24% undervalued after recent price drop

Align Technology, Inc. Announces Executive Appointments

Now 20% undervalued after recent price drop

Align Technology, Inc. Revises Earnings Guidance for the Fiscal Full Year 2024

First quarter 2024 earnings released: EPS: US$1.40 (vs US$1.14 in 1Q 2023)

Align Technology, Inc. Provides Earnings Guidance for the Second Quarter of 2024

Align Technology, Inc., Annual General Meeting, May 22, 2024

Full year 2023 earnings released: EPS: US$5.82 (vs US$4.62 in FY 2022)

Independent Director recently sold US$7.7m worth of stock

U.S. District Court for Northern District of California Grants Summary Judgment in Favor of Align Technology, Inc. in Two Antitrust Class Action Lawsuits

Full year 2023 earnings released: EPS: US$5.82 (vs US$4.62 in FY 2022)

Align Technology, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2024

Now 21% overvalued after recent price rise

Investor sentiment improves as stock rises 21%

Align Technology, Inc. Receives US FDA 510(K) Clearance for the Invisalign Palatal Expander System to Address Skeletal and Dental Expansion in Growing Patients, Including Teenage Patients Which Represent the Majority of Orthodontic Case Starts Globally

Health Canada Issues Medical Device License to Align Technology for the Invisalign® Palatal Expander System to Address Skeletal and Dental Expansion

Align Technology, Inc. Announces Board Appointments

President recently bought US$1m worth of stock

President recently bought US$1m worth of stock

Investor sentiment deteriorates as stock falls 31%

New minor risk - Share price stability

Now 32% undervalued after recent price drop

Align Technology, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year of 2023

Third quarter 2023 earnings released: EPS: US$1.59 (vs US$0.93 in 3Q 2022)

Align Technology, Inc. (NasdaqGS:ALGN) entered into a definitive agreement to acquire additional unknown stake in Cubicure GmbH for €79 million.

Superior Court of California, County of Santa Clara, Confirms $63 Million Arbitration Award in Favor of Align Technology and Denies SmileDirectClub’s Motion to Vacate

New minor risk - Share price stability

Align Technology, Inc. Provides Revenue Guidance for the Third Quarter and Full Year of 2023

Second quarter 2023 earnings released: EPS: US$1.46 (vs US$1.44 in 2Q 2022)

Align Technology, Inc.(NasdaqGS:ALGN) dropped from Russell 1000 Value Index

Independent Director recently bought US$2.0m worth of stock

First quarter 2023 earnings released: EPS: US$1.14 (vs US$1.71 in 1Q 2022)

President recently bought US$1m worth of stock

Align Technology, Inc. Announces Executive Changes in iTero Scanner and Services

Full year 2022 earnings released: EPS: US$4.62 (vs US$9.78 in FY 2021)

Investor sentiment improves as stock rises 38%

Align Technology, Inc. (NasdaqGS:ALGN) announces an Equity Buyback for $1,000 million worth of its shares.

Align Technology, Inc. to Report Q4, 2022 Results on Feb 01, 2023

Now 20% undervalued after recent price drop

DentalMonitoring SAS Files Patent Infringement Lawsuit Asserting Three Patents Against Align Technology, Inc

Insufficient new directors

President recently bought US$2.0m worth of stock

Third quarter 2022 earnings released: EPS: US$0.93 (vs US$2.29 in 3Q 2021)

Align Technology, Inc. Introduces Latest Itero-Exocad Connector™ Software Release That Enables Advanced Visualization for Doctors and Labs, with Seamless Integration of Itero™ Intraoral Camera and Niri Images Within Exocad™ Software

Align Technology, Inc. Introduces Invisalign Virtual Care AI

Second quarter 2022 earnings released: EPS: US$1.44 (vs US$2.53 in 2Q 2021)

Insufficient new directors

Align Technology, Inc. Introduces Invisalign Outcome Simulator Pro

First quarter 2022 earnings released: EPS: US$1.71 (vs US$2.54 in 1Q 2021)

Now 37% undervalued after recent price drop

Insufficient new directors

Now 23% undervalued after recent price drop

Align Technology, Inc., Annual General Meeting, May 18, 2022

Investor sentiment improved over the past week

Now 23% undervalued after recent price drop

Align Technology, Inc. Announces Settlement of Outstanding Litigation with 3Shape A/S

Now 22% undervalued after recent price drop

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Align Technology, Inc. Announces Invisalign System Innovations for the Align Digital Platform

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

CFO & Senior VP of Global Finance recently sold US$2.1m worth of stock

Third quarter 2021 earnings released: EPS US$2.29 (vs US$1.77 in 3Q 2020)

Independent Director recently sold US$3.6m worth of stock

Insider recently sold US$6.5m worth of stock